ribavirin has been researched along with tegobuvir in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Agarwal, K; Arterburn, S; Buggisch, P; Foster, GR; Horsmans, Y; Klinker, H; Knox, S; Manns, MP; Marcellin, P; McHutchison, JG; Mo, H; Moreno, C; Oldach, D; Sereni, D; Zarski, JP; Zeuzem, S | 1 |
| Cheng, G; Corsa, AC; Delaney, WE; Kim, CU; Krawczyk, S; Mo, H; Pakdaman, R; Peng, B; Qi, X; Robinson, M; Shen, M; Sheng, XC; Tay, C; Tian, Y; Wang, Y; Yang, C; Yang, H | 1 |
| Brainard, DM; Habersetzer, F; Herring, RW; Kanwar, B; Lawitz, E; Massetto, B; McHutchison, JG; Mo, H; Pang, PS; Pol, S; Rodriguez-Torres, M; Shiffman, ML; Subramanian, GM; Sulkowski, MS; Trenkle, JD; Wyles, DL; Zhu, Y | 1 |
| Neyts, J; Paeshuyse, J; Vliegen, I; Zhong, W | 1 |
2 trial(s) available for ribavirin and tegobuvir
| Article | Year |
|---|---|
The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C.
Topics: Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Peptides, Cyclic; Phosphinic Acids; Polyethylene Glycols; Protease Inhibitors; Purines; Pyridazines; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2012 |
All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Benzimidazoles; Drug Resistance, Viral; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Purines; Pyridazines; Quinolines; Ribavirin; Treatment Outcome; Viral Nonstructural Proteins; Young Adult | 2014 |
3 other study(ies) available for ribavirin and tegobuvir
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451.
Topics: Animals; Antiviral Agents; Benzimidazoles; Dogs; Drug Evaluation, Preclinical; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Fluorenes; Haplorhini; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Humans; Inhibitory Concentration 50; Interferon-alpha; Protease Inhibitors; Purines; Pyridazines; Quinolines; Rats; Replicon; Ribavirin; Viral Nonstructural Proteins | 2014 |
In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance.
Topics: Antiviral Agents; Cell Line; Drug Resistance, Viral; Drug Synergism; Hepacivirus; Hepatocytes; Humans; Interferon-alpha; Oligopeptides; Purines; Pyridazines; Ribavirin; RNA, Viral | 2015 |